<p>Rapid Micro Biosystems（纳斯达克代码：RPID - 获取免费报告）于周五发布了其财报。该公司报告本季度每股收益为（$0.26），符合市场共识预期的（$0.26），Zacks 报道。Rapid Micro Biosystems 的股本回报率为负 63.07%，净利润率为负 145.63%。该公司本季度的收入为 784 万美元，高于分析师预期的 760 万美元。Rapid Micro Biosystems 更新了其 2025 财年的每股收益指引。</p>
<p>获取 <strong>Rapid Micro Biosystems</strong> 的提醒：</p>
<h2>Rapid Micro Biosystems 股票表现</h2>
<p>周五午盘交易中，Rapid Micro Biosystems 的股票上涨了 0.35 美元，达到 3.10 美元。该公司共交易了 127,335 股股票，而其平均交易量为 82,886 股。该股票的 50 日移动平均为 3.06 美元，200 日移动平均为 3.13 美元。Rapid Micro Biosystems 的 12 个月低点为 0.87 美元，12 个月高点为 4.50 美元。该公司的市值为 1.3705 亿美元，市盈率为-3.07，贝塔值为 1.37。</p>
<h2>对 Rapid Micro Biosystems 的对冲基金看法</h2>
<p>机构投资者最近买入和卖出了该股票的股份。先锋集团在第三季度增持了 Rapid Micro Biosystems 的股份，增幅为 6.7%。先锋集团目前拥有 965,018 股该公司的股票，价值 3,223,000 美元，此前在上个季度增持了 60,655 股。Geode Capital Management LLC 在第二季度增持了 Rapid Micro Biosystems 的股份，增幅为 1.6%。Geode Capital Management LLC 目前拥有 204,079 股该公司的股票，价值 704,000 美元，此前在上个季度增持了 3,143 股。XTX Topco Ltd 在第二季度购买了 Rapid Micro Biosystems 的新股份，价值约为 144,000 美元。最后，美国世纪公司在第二季度增持了 Rapid Micro Biosystems 的股份，增幅为 46.1%。美国世纪公司目前拥有 16,922 股该公司的股票，价值 58,000 美元，此前在此期间增持了 5,341 股。52.60% 的股票由机构投资者持有。</p>
<h2>分析师设定新目标价</h2>
<p>几位分析师对该公司发表了看法。Lake Street Capital 在 7 月 28 日的研究报告中开始覆盖 Rapid Micro Biosystems。他们给予该公司 “买入” 评级，目标价为 8.00 美元。Weiss Ratings 在 10 月 8 日的报告中重申了对 Rapid Micro Biosystems 股票的 “卖出（d-）” 评级。最后，华尔街 Zen 在 9 月 13 日的报告中将 Rapid Micro Biosystems 的股票评级从 “卖出” 上调至 “持有”。一位分析师给予该股票 “强烈买入” 评级，一位给予 “买入” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为 8.00 美元。</p>
<p><strong>查看我们关于 RPID 的最新研究报告</strong></p>
<h2>Rapid Micro Biosystems 公司简介</h2>
<p>（获取免费报告）</p>
<p>Rapid Micro Biosystems, Inc 是一家生命科学技术公司，提供用于检测美国、德国、瑞士、日本及国际市场上制药、医疗器械和个人护理产品生产中的微生物污染的产品。该公司提供 Growth Direct 平台，包括 Growth Direct 系统、专有耗材、实验室信息管理系统连接软件以及客户支持和验证服务。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 Rapid Micro Biosystems 更好</li>
<li>什么是债券市场假期？如何投资和交易</li>
<li>OpenAI 的重组可能会成为有史以来最大的 IPO</li>
<li>哪里可以找到财报电话会议记录</li>
<li>2 只美国政府不希望失败的稀土股票</li>
<li>如何从成长投资中获利</li>
<li>CrowdStrike 与 CoreWeave 合作，但投资者抛售消息</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UlBJRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UlBJRA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Rapid Micro Biosystems 吗？</h2>
<p>在你考虑 Rapid Micro Biosystems 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Rapid Micro Biosystems 并不在名单上。</p>
<p>虽然 Rapid Micro Biosystems 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

RPID

<p>Rapid Micro Biosystems（纳斯达克代码：RPID）报告的季度每股收益为（$0.26），符合分析师的预期。该公司实现了 784 万美元的收入，超过了 760 万美元的预估。尽管净利润率为负的 145.63%，股本回报率为-63.07%，机构投资者仍然增加了他们的持股。分析师的评级意见不一，普遍评级为 “适度买入”，目标价为 8.00 美元。该股票交易价格为 3.10 美元，反映出 12 个月的价格区间为 0.87 美元至 4.50 美元</p>

<p>Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) issued its earnings results on Friday. The company reported ($0.26) earnings per share for the quarter, meeting the consensus estimate of ($0.26), Zacks reports. Rapid Micro Biosystems had a negative return on equity of 63.07% and a negative net margin of 145.63%.The company had revenue of $7.84 million during the quarter, compared to analysts' expectations of $7.60 million. Rapid Micro Biosystems updated its FY 2025 guidance to EPS.</p>
<div class="lb-trans"><p>Rapid Micro Biosystems（纳斯达克代码：RPID - 获取免费报告）于周五发布了其财报。该公司报告本季度每股收益为（$0.26），符合市场共识预期的（$0.26），Zacks 报道。Rapid Micro Biosystems 的股本回报率为负 63.07%，净利润率为负 145.63%。该公司本季度的收入为 784 万美元，高于分析师预期的 760 万美元。Rapid Micro Biosystems 更新了其 2025 财年的每股收益指引。</p>
</div><p>Get <strong>Rapid Micro Biosystems</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Rapid Micro Biosystems</strong> 的提醒：</p>
</div><h2>Rapid Micro Biosystems Stock Performance</h2>
<div class="lb-trans"><h2>Rapid Micro Biosystems 股票表现</h2>
</div><p>Shares of Rapid Micro Biosystems stock traded up $0.35 during midday trading on Friday, reaching $3.10. 127,335 shares of the company's stock traded hands, compared to its average volume of 82,886. The stock has a 50 day moving average of $3.06 and a 200-day moving average of $3.13. Rapid Micro Biosystems has a 12 month low of $0.87 and a 12 month high of $4.50. The company has a market cap of $137.05 million, a PE ratio of -3.07 and a beta of 1.37.</p>
<div class="lb-trans"><p>周五午盘交易中，Rapid Micro Biosystems 的股票上涨了 0.35 美元，达到 3.10 美元。该公司共交易了 127,335 股股票，而其平均交易量为 82,886 股。该股票的 50 日移动平均为 3.06 美元，200 日移动平均为 3.13 美元。Rapid Micro Biosystems 的 12 个月低点为 0.87 美元，12 个月高点为 4.50 美元。该公司的市值为 1.3705 亿美元，市盈率为-3.07，贝塔值为 1.37。</p>
</div><h2>Hedge Funds Weigh In On Rapid Micro Biosystems</h2>
<div class="lb-trans"><h2>对 Rapid Micro Biosystems 的对冲基金看法</h2>
</div><p>Institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in Rapid Micro Biosystems by 6.7% during the 3rd quarter. Vanguard Group Inc. now owns 965,018 shares of the company's stock valued at $3,223,000 after acquiring an additional 60,655 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Rapid Micro Biosystems by 1.6% during the second quarter. Geode Capital Management LLC now owns 204,079 shares of the company's stock valued at $704,000 after purchasing an additional 3,143 shares in the last quarter. XTX Topco Ltd bought a new stake in shares of Rapid Micro Biosystems during the second quarter valued at approximately $144,000. Finally, American Century Companies Inc. grew its stake in Rapid Micro Biosystems by 46.1% in the second quarter. American Century Companies Inc. now owns 16,922 shares of the company's stock worth $58,000 after purchasing an additional 5,341 shares during the period. 52.60% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>机构投资者最近买入和卖出了该股票的股份。先锋集团在第三季度增持了 Rapid Micro Biosystems 的股份，增幅为 6.7%。先锋集团目前拥有 965,018 股该公司的股票，价值 3,223,000 美元，此前在上个季度增持了 60,655 股。Geode Capital Management LLC 在第二季度增持了 Rapid Micro Biosystems 的股份，增幅为 1.6%。Geode Capital Management LLC 目前拥有 204,079 股该公司的股票，价值 704,000 美元，此前在上个季度增持了 3,143 股。XTX Topco Ltd 在第二季度购买了 Rapid Micro Biosystems 的新股份，价值约为 144,000 美元。最后，美国世纪公司在第二季度增持了 Rapid Micro Biosystems 的股份，增幅为 46.1%。美国世纪公司目前拥有 16,922 股该公司的股票，价值 58,000 美元，此前在此期间增持了 5,341 股。52.60% 的股票由机构投资者持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Several analysts have weighed in on the company. Lake Street Capital began coverage on Rapid Micro Biosystems in a research report on Monday, July 28th. They issued a &#34;buy&#34; rating and a $8.00 price objective for the company. Weiss Ratings reiterated a &#34;sell (d-)&#34; rating on shares of Rapid Micro Biosystems in a report on Wednesday, October 8th. Finally, Wall Street Zen raised shares of Rapid Micro Biosystems from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Saturday, September 13th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $8.00.</p>
<div class="lb-trans"><p>几位分析师对该公司发表了看法。Lake Street Capital 在 7 月 28 日的研究报告中开始覆盖 Rapid Micro Biosystems。他们给予该公司 “买入” 评级，目标价为 8.00 美元。Weiss Ratings 在 10 月 8 日的报告中重申了对 Rapid Micro Biosystems 股票的 “卖出（d-）” 评级。最后，华尔街 Zen 在 9 月 13 日的报告中将 Rapid Micro Biosystems 的股票评级从 “卖出” 上调至 “持有”。一位分析师给予该股票 “强烈买入” 评级，一位给予 “买入” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为 8.00 美元。</p>
</div><p><strong>Check Out Our Latest Research Report on RPID</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 RPID 的最新研究报告</strong></p>
</div><h2>Rapid Micro Biosystems Company Profile</h2>
<div class="lb-trans"><h2>Rapid Micro Biosystems 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.</p>
<div class="lb-trans"><p>Rapid Micro Biosystems, Inc 是一家生命科学技术公司，提供用于检测美国、德国、瑞士、日本及国际市场上制药、医疗器械和个人护理产品生产中的微生物污染的产品。该公司提供 Growth Direct 平台，包括 Growth Direct 系统、专有耗材、实验室信息管理系统连接软件以及客户支持和验证服务。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Rapid Micro Biosystems</li>
<li>What is a Bond Market Holiday? How to Invest and Trade</li>
<li>OpenAI's Restructuring Sets up What Could Be the Biggest IPO Ever</li>
<li>Where to Find Earnings Call Transcripts</li>
<li>2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail</li>
<li>How to Profit From Growth Investing</li>
<li>CrowdStrike Partners With CoreWeave But Investors Sell the News</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Rapid Micro Biosystems 更好</li>
<li>什么是债券市场假期？如何投资和交易</li>
<li>OpenAI 的重组可能会成为有史以来最大的 IPO</li>
<li>哪里可以找到财报电话会议记录</li>
<li>2 只美国政府不希望失败的稀土股票</li>
<li>如何从成长投资中获利</li>
<li>CrowdStrike 与 CoreWeave 合作，但投资者抛售消息</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UlBJRA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=RPID"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Rapid Micro Biosystems Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Rapid Micro Biosystems 吗？</h2>
</div><p>Before you consider Rapid Micro Biosystems, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Rapid Micro Biosystems 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rapid Micro Biosystems wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Rapid Micro Biosystems 并不在名单上。</p>
</div><p>While Rapid Micro Biosystems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Rapid Micro Biosystems 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Rapid Micro Biosystems（纳斯达克股票代码：RPID）公布了财报，业绩符合预期